Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing.

Related Keywords

Philadelphia , Pennsylvania , United States , Beverly Davidson , Latus Bio , Benjamin Franklin Technology Partners , Children Hospital Of Philadelphia Foundation , Samsung Life Science Fund , Philadelphia Foundation , Modi Ventures , Peter Ghoroghchian ,